Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Propranolol LA is a generic equivalent of Inderal LA
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
This product will be manufactured at Lupin's Pithampur facility in India
The company has entered into a three-year Deferred Prosecution Agreement
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Subscribe To Our Newsletter & Stay Updated